2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)

Jiri Slama; Ingo Runnebaum; Giovanni Scambia; Martina Aida Angeles; Kiarash Bahrehmand; Stefan Kommoss; Anna Fagotti; Fabrice Narducci; Olga Matylevich; Jessica Holly; Fabio Martinelli; Meriem Koual; Viacheslav Kopetskyi; Ahmed El-Balat; Giacomo Corrado; Mihai Emil Capilna; Willibald Schroder; Zoltan Novak; Alexander Shushkevich; Lenka Fricova; David Cibula

doi:10.1136/ijgc-2022-ESGO.372

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Alerts

PDF

Fertility/Pregnancy

2022-RA-689-ESGO Fertility-sparing treatment in patients with IB1 cervical cancer – results of the international multicentre retrospective FERTISS study (ENGOT Cx14; CEEGOG Cx-03)

Free

Log in using your username and password

Main menu

Log in using your username and password

You are here

Read the full text or download the PDF:

Log in using your username and password